Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 346

Sort by

Sort Order Select

Journal Articles

Human CD83 Targeted Chimeric Antigen Receptor T Cell for the Prevention of Graft Versus Host Disease and Treatment of Myeloid Leukemia

Bishwas Shrestha, PhD, Kelly Walton, Jordan Reff, Elizabeth M. Sagatys, MD, Nhan Tu, PhD, Justin C. Boucher, PhD, Tayyeb Ghafoor, BS, Joseph Pidala, MD, Bruce R. Blazar, MD, Claudio Anasetti, MD, Brian C. Betts, MD, Marco L. Davila, MD PhD

Blood (2019) 134 (Supplement_1): 196.

https://doi.org/10.1182/blood-2019-124031

Published: 2019

Journal Articles

Non-Hematopoietic Lymphoid Stromal Cells Prime Alloreactive CD4 + T Cells in Acute Graft-Versus-Host Disease

Muhammad Shaikh, MSc, Maria Ulbrich, MSc, Juan Gamboa Vargas, BSc, Katja J Ottmüller, PhD, Duc Dung Le, PhD, Zeinab Mokthari, PhD, Joern Pezoldt, PhD, Hermann Einsele, MD, Burkhard Ludewig, PhD, Jochen Huehn, PhD, Andreas Beilhack, MD

Blood (2019) 134 (Supplement_1): 4421.

https://doi.org/10.1182/blood-2019-125665

Published: 2019

Journal Articles

The Immunomodulatory Effect of Triptolide on Mesenchymal Stem Cells in Vitro

Haiping He, MD PhD, Atsuko Takahashi, MT., Yuki Yamamoto, MT, Akiko Hori, Yuta Miharu, MT, Kazuaki Yokoyama, MD PhD, Miwako Narita, MD PhD, Fumitaka Nagamura, MD PhD, Arinobu Tojo, MD PhD, Tonghua Yang, MD PhD, Tokiko Nagamura-Inoue, MD PhD

Blood (2019) 134 (Supplement_1): 5011.

https://doi.org/10.1182/blood-2019-125046

Published: 2019

Journal Articles

Therapeutic Targeting of RUNX-NFATC2 Axis for Acute Promyelocytic Leukemia and T Cell Immunity

Hirohito Kubota, MD, Kana Furuichi, Tatsuya Masuda, Toshiya Tatsuta, Hidefumi Hiramatsu, MD PhD, Junko Takita, MD PhD, Sugiyama Hiroshi, PhD, Souichi Adachi, MD PhD, Yasuhiko Kamikubo, MD, PhD

Blood (2019) 134 (Supplement_1): 3359.

https://doi.org/10.1182/blood-2019-126428

Published: 2019

Journal Articles

Discovery of DWP213388, a Potent ITK and BTK Selective Dual Inhibitor with Excellent Efficacy and Safety, for Treating Gvhd

Deokki Eom, BS, Jae Hun Jung, Eun Kyung KIM, PhD, Wolyoung Kim, Qingri Li, Jaehyun Jung, Sohee Im, Yong Dae Shin, Hyaejung Hyun, Joon Seok Park

Blood (2019) 134 (Supplement_1): 4426.

https://doi.org/10.1182/blood-2019-126839

Published: 2019

Journal Articles

Role of MMP-13 in Graft-Versus-Host Disease

Hui-Hui Ma, PhD, Jing Fu, PhD, Suzanne Lentzsch, MD PhD, Markus Y Mapara, MD PhD

Blood (2019) 134 (Supplement_1): 1928.

https://doi.org/10.1182/blood-2019-127703

Published: 2019

Journal Articles

Immunosuppressive Diversity of Umbilical Cord-Derived Mesenchymal Stromal Cells

Tokiko Nagamura-Inoue, MD PhD, Atsuko Takahashi, MT., Yuki Yamamoto, MT, Akiko Hori, Yuta Miharu, MT, Kazuo Ogami, MT, Miwako Narita, MD PhD, Fumitaka Nagamura, MD PhD, Arinobu Tojo, MD PhD

Blood (2019) 134 (Supplement_1): 3584.

https://doi.org/10.1182/blood-2019-128627

Published: 2019

Journal Articles

Ruxolitinib, a JAK1/JAK2 Selective Inhibitor, Ameliorates Gastrointestinal and Cutaneous Pathogenesis in MHC-Mismatched Preclinical Models of Acute and Chronic Graft-Versus-Host Disease

Eduardo Huarte, PhD, Melissa Parker, Ashish Juvekar, Julian Oliver, Wenqing Yao, Paul Smith

Blood (2019) 134 (Supplement_1): 5608.

https://doi.org/10.1182/blood-2019-126749

Published: 2019

Journal Articles

Targeting Intestinal Vitamin D Receptor Signaling to Mitigate Graft-Versus-Host Disease

Brian Taylor, Jie Du, Joseph Dodge, Yan Chun Li, PhD, Xiao Chen, MD PhD

Blood (2018) 132 (Supplement 1): 4515.

https://doi.org/10.1182/blood-2018-99-117109

Published: 2018

Journal Articles

RNA-Seq of Human T Cells after BMT Identifies Linc00402 As a Novel Regulator of Human T Cell Alloimmunity

Dan Peltier, MD, Nicolas Robine, Guoqing Hou, PhD, Pavan Reddy, MD

Blood (2018) 132 (Supplement 1): 4517.

https://doi.org/10.1182/blood-2018-99-113017

Published: 2018

Journal Articles

Pluripotent Cell-Derived Off-the-Shelf TCR-Less CAR-Targeted Cytotoxic T Cell Therapeutic for the Allogeneic Treatment of B Cell Malignancies

Blood (2018) 132 (Supplement 1): 4546.

https://doi.org/10.1182/blood-2018-99-116843

Published: 2018

Journal Articles

Expression of the Butyrate/Niacin Receptor, GPR109a on T Cells Plays an Important Role in a Mouse Model of Graft Versus Host Disease

Melissa D Docampo, BS, Christoph K. Stein-Thoeringer, MD, Amina Lazrak, BS, Marina D Burgos da Silva, PhD, Justin Cross, PhD, Marcel R.M. van den Brink, MD PhD

Blood (2018) 132 (Supplement 1): 61.

https://doi.org/10.1182/blood-2018-99-118783

Published: 2018

Journal Articles

A Protein-Based Method to Develop Allogeneic Chimeric Antigen Receptor T-Cells

Paul Maciocia, BSc, MBChB, MRCP, Patrycja Wawrzyniecka, Leo Kassimatis, Martin Pule, MD

Blood (2018) 132 (Supplement 1): 700.

https://doi.org/10.1182/blood-2018-99-112544

Published: 2018

Journal Articles

The BCL-2-Selective Inhibitor Venetoclax Spares Activated T-Cells during Anti-Tumor Immunity

Rebecca Mathew, PhD, Dipica Haribhai, PhD, Fred Kohlhapp, PhD, Ryan Duggan, Paul Ellis, Jacob J Riehm, Valerie A Robinson, Yan Y Shi, Anahita Bhathena, PhD, Joel D. Leverson, PhD, William N Pappano, Cherrie K Donawho, PhD, Tamar Uziel, PhD

Blood (2018) 132 (Supplement 1): 3704.

https://doi.org/10.1182/blood-2018-99-113134

Published: 2018

Journal Articles

CRISPR/Cas9-Mediated Disruption of PD-L1 Reduces the T Cell Suppressive Effect of Wharton's Jelly Mesenchymal Stromal Cells and Their Extracellular Vesicles

Neil Dunavin, MD, Meizhang Li, PhD, Safinur Atay, PhD, Jim Mitchell, Rupal Soder, PhD, Sunil Abhyankar, MD, Joseph P. McGuirk, DO, Andrew K Godwin, PhD, Buddhadeb Dawn, MD

Blood (2018) 132 (Supplement 1): 5095.

https://doi.org/10.1182/blood-2018-99-116921

Published: 2018

Journal Articles

CD200 Is a Stem Cell-Specific Immunosuppressive Target in AML

Shelley Herbrich, MS, Keith Baggerly, PhD, Gheath Alatrash, DO, PhD, R. Eric Davis, MD, Michael Andreeff, MD PhD, Marina Y. Konopleva, MD PhD

Blood (2018) 132 (Supplement 1): 2768.

https://doi.org/10.1182/blood-2018-99-114818

Published: 2018

Journal Articles

How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation

Blood (2018) 132 (Supplement 1): 3333.

https://doi.org/10.1182/blood-2018-99-112512

Published: 2018

Journal Articles

Interferon Regulatory Factor 4 Is a Key Factor in Regulation of T helper Cell Polarization in Graft-Versus-Host Disease

Jochen T Frueh, MSc, BSc, Bushra Rais, PhD, Daniele Yumi Sunaga-Franze, Katja Stein, Sascha Sauer, PhD, Andreas G Chiocchetti, PhD, Michael Lohoff, PhD, Evelyn Ullrich, MD

Blood (2018) 132 (Supplement 1): 3313.

https://doi.org/10.1182/blood-2018-99-116151

Published: 2018

Journal Articles

Bendamustine Conditioning Alters Host Dendritic Cell Composition and Function

Megan Stanley Molina, BS, MS, Jessica Stokes, BS, Emely Hoffman, BS, Emmanuel Katsanis, MD

Blood (2018) 132 (Supplement 1): 5670.

https://doi.org/10.1182/blood-2018-99-117140

Published: 2018

Journal Articles

Development of Potency Assays for Quality Assessment of an Advanced Therapy Medicinal Product: Mitomycin C-Induced Peripheral Blood Mononuclear Cell (MIC) Product

Ming NI, Lei Wang, MD, Christian Kleist, PhD, Peter Terness, MD, Gerhard Opelz, MD, Christian Morath, MD, Matthias Schaier, MD, Carsten Müller-Tidow, MD, Martin Zeier, MD, Michael Schmitt, MD PhD, Anita Schmitt, MD

Blood (2018) 132 (Supplement 1): 5689.

https://doi.org/10.1182/blood-2018-99-113337

Published: 2018

NARROW

Human CD83 Targeted Chimeric Antigen Receptor T Cell for the Prevention of Graft Versus Host Disease and Treatment of Myeloid Leukemia

Non-Hematopoietic Lymphoid Stromal Cells Prime Alloreactive CD4 + T Cells in Acute Graft-Versus-Host Disease

The Immunomodulatory Effect of Triptolide on Mesenchymal Stem Cells in Vitro

Therapeutic Targeting of RUNX-NFATC2 Axis for Acute Promyelocytic Leukemia and T Cell Immunity

Discovery of DWP213388, a Potent ITK and BTK Selective Dual Inhibitor with Excellent Efficacy and Safety, for Treating Gvhd

Role of MMP-13 in Graft-Versus-Host Disease

Immunosuppressive Diversity of Umbilical Cord-Derived Mesenchymal Stromal Cells

Ruxolitinib, a JAK1/JAK2 Selective Inhibitor, Ameliorates Gastrointestinal and Cutaneous Pathogenesis in MHC-Mismatched Preclinical Models of Acute and Chronic Graft-Versus-Host Disease

Targeting Intestinal Vitamin D Receptor Signaling to Mitigate Graft-Versus-Host Disease

RNA-Seq of Human T Cells after BMT Identifies Linc00402 As a Novel Regulator of Human T Cell Alloimmunity

Pluripotent Cell-Derived Off-the-Shelf TCR-Less CAR-Targeted Cytotoxic T Cell Therapeutic for the Allogeneic Treatment of B Cell Malignancies

Expression of the Butyrate/Niacin Receptor, GPR109a on T Cells Plays an Important Role in a Mouse Model of Graft Versus Host Disease

A Protein-Based Method to Develop Allogeneic Chimeric Antigen Receptor T-Cells

The BCL-2-Selective Inhibitor Venetoclax Spares Activated T-Cells during Anti-Tumor Immunity

CRISPR/Cas9-Mediated Disruption of PD-L1 Reduces the T Cell Suppressive Effect of Wharton's Jelly Mesenchymal Stromal Cells and Their Extracellular Vesicles

CD200 Is a Stem Cell-Specific Immunosuppressive Target in AML

How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation

Interferon Regulatory Factor 4 Is a Key Factor in Regulation of T helper Cell Polarization in Graft-Versus-Host Disease

Bendamustine Conditioning Alters Host Dendritic Cell Composition and Function

Development of Potency Assays for Quality Assessment of an Advanced Therapy Medicinal Product: Mitomycin C-Induced Peripheral Blood Mononuclear Cell (MIC) Product

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only